Jerry L. Spivak - Concepedia

Author

Jerry L. Spivak

Also Known As

J L Spivak, J SPIVAK, J Spivak, J. L. SPIVAK, J. L. Spivak, J.L Spivak, J.L. Spivak, JERRY L. SPIVAK, Jerry L Spivak, Jerry L. Spivak

322

Publications

11.4K

Citations

H-Index

157

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Northwestern University Johns Hopkins Hospital Sidney Kimmel Comprehensive Cancer Center

About

Jerry L. Spivak is an author at Johns Hopkins University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	51	4K
2	Health Sciences	14	14	806
3	Public Health	5	5	234
4	Social Sciences	1	1	37
5	Biochemistry	1	1	30

Jerry L. Spivak

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Decreased Erythropoietin Response in Patients with the Anemia of Cancer Carole B. Miller, Richard J. Jones, Steven Piantadosi, New England Journal of Medicine AnemiaHematological MalignancyIron-deficiency AnemiaOncologyBone Marrow Failure	1990	669
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Zhaohui Ye, Huichun Zhan, Prashant Mali, Blood	2009	379
Hematophagic Histiocytosis Alexander P. Reiner, Jerry L. Spivak Medicine Bone Marrow FailureAutoimmune DiseaseHepatologyHepatitis CLaboratory Hematology	1988	371
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera Alison R. Moliterno, W. David Hankins, Jerry L. Spivak New England Journal of Medicine	1998	310
Hematologic abnormalities in the acquired immune deficiency syndrome Jerry L. Spivak, Bradley S. Bender, Thomas C. Quinn The American Journal of Medicine Primary ImmunodeficiencyAutoimmune DiseaseHematologyImmunologyAutoimmunity	1984	274
Serum Immunoreactive Erythropoietin in HIV-Infected Patients Jerry L. Spivak JAMA Primary ImmunodeficiencyAnemiaMean Sie LevelHuman Immunodeficiency VirusAutoimmune Disease	1989	237
Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia Damiano Rondelli, Giovanni Barosi, Andrea Bacigalupo, Blood	2005	200
Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation Martin Carroll, Jerry L. Spivak, Michael T. McMahon, Journal of Biological Chemistry Raf-1 Kinase ActivityImmunologyImmune RegulationCell DeathBlood Cell	1991	185
Detection, Evaluation, and Management of Anemia in the Elective Surgical Patient Lawrence T. Goodnough, Aryeh Shander, Jerry L. Spivak, Anesthesia & Analgesia AnemiaElective Surgical PatientMedicineBlood TransfusionHematology	2005	163
Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia Marc C. Hochberg, Cynthia M. Arnold, Beth B. Murinson, Arthritis & Rheumatism	1988	139

Page 1